Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitis
Publikation: Beitrag in Fachzeitschrift › Fallbericht (Case report) › Beigetragen › Begutachtung
Beitragende
Abstract
BACKGROUND: There are only a few reports of pulmonary hypertension (PH) in hypersensitivity pneumonitis (HP) and an approved vasomodulatory therapy for PH does not exist at all for interstitial lung disease (ILD), particularly for HP.
CASE REPORT: The case of a 53-year-old woman with chronic HP and severe life-threatening PH treated with a combined specific vasomodulatory therapy is reported. Sustained clinical and hemodynamic improvement was achieved.
CONCLUSIONS: Further investigation of PH in HP and specific vasomodulatory therapy is necessary.
Details
| Originalsprache | Englisch |
|---|---|
| Seiten (von - bis) | CS55-7 |
| Fachzeitschrift | Medical science monitor : international medical journal of experimental and clinical research |
| Jahrgang | 16 |
| Ausgabenummer | 5 |
| Publikationsstatus | Veröffentlicht - Mai 2010 |
| Peer-Review-Status | Ja |
Externe IDs
| Scopus | 77954251411 |
|---|---|
| PubMed | 20424556 |
| ORCID | /0000-0001-6022-6827/work/142659542 |
Schlagworte
Schlagwörter
- Alveolitis, Extrinsic Allergic/complications, Chronic Disease, Drug Therapy, Combination, Female, Humans, Hypertension, Pulmonary/complications, Iloprost/administration & dosage, Middle Aged, Phenylpropionates/therapeutic use, Piperazines/administration & dosage, Purines/administration & dosage, Pyridazines/therapeutic use, Sildenafil Citrate, Sulfones/administration & dosage, Vasodilator Agents/therapeutic use